Clinical and Quality of Life Outcomes Following Temperature-Controlled Radiofrequency Neurolysis of the Posterior Nasal Nerve (RhinAer) for Treatment of Chronic Rhinitis.

Jivianne T LeeGregory M AbbasDaniel D CharousPd Dr Med Mandy CuevasProf Dr Med Önder GöktasPatricia A LoftusNathan E NachlasElina M ToskalaJeremy P WatkinsProf Dr Med Detlef Brehmer

Published in: American journal of rhinology & allergy (2022)

In this large, multicenter study, TCRF neurolysis of the PNN was safe and resulted in a significant reduction in rhinitis symptom burden at 3 months that was sustained/improved through 6 months. The majority of patients reported a clinically relevant improvement in QoL at 3 and 6 months postprocedure.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
risk factors
patient reported outcomes
ultrasound guided